Pro-protein converting enzyme
US6380171B1 · kind B1 · utility
13Cited by
1References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 13, 1999 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | Sep 13, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the cloning of human pro-protein converting enzyme 5 (PC5) CDNA isolated from human adrenal gland messenger RNA. Additionally, this invention relates to a method for reducing restenosis occurring at an injured vascular site comprising delivering to the injured site an antisense nucleic acid to suppress the expression of human PC5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.